insights_auto
Why is CHGCF down 2.13%?
Dive Deeperchevron_right
CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
$ 39.59
arrow_downward
-2.13%(-0.86) 1D
9-р сарын 29, 16:00:00 (GMT-4) · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
$ 37.49
High
$ 39.72
Low
$ 36.37
Mkt. cap
10.38ИН
Avg. vol.
9.89 мян
Volume
7.97 мян
52-wk high
$ 68.08
52-wk low
$ 34.79
Beta
2.12
Shares outstanding
1.68 тэрбум
No. of employees
5 мян
Open
$ 37.49
High
$ 39.72
Low
$ 36.37
Mkt. cap
10.38ИН
Avg. vol.
9.89 мян
Volume
7.97 мян
52-wk high
$ 68.08
52-wk low
$ 34.79
Beta
2.12
Shares outstanding
1.68 тэрбум
No. of employees
5 мян
News stories
From web sources and news partners
Investing.com Canada
·
22 цагийн өмнө
Why is Chugai Pharmaceutical stock sliding today? By Investing.com
TipRanks
·
1 өдрийн өмнө
Chugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1 мян
Founded1925 оны 3-р сарын 10
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp